{ "meta": { "title": "CT 技术前沿专题指南与专家共识数据库（增补分册）", "version": "1.0", "updated": "2026-09-22", "scope": "按 15 个 CT 技术专题归集的指南/共识/技术规范/行业标准；仅收录现有 guidelines_cn_part1.json 与 guidelines_intl_part1.json 尚未收录的净新增条目，避免重复。", "fields": "cn=中文名称, en=英文名称, org=发布机构, year=年份, source=出处, region=地区, cat=学科分类, tech=CT技术标签, topics=所属技术专题, summary=核心内容, points=CT技术相关点, url=来源", "topics": [ { "no": 1, "name": "光子计数CT（PCCT）", "records": [ "CN-CSR-001", "INTL-SAR-001", "TECH-PCCT-001" ] }, { "no": 2, "name": "能谱成像/双能CT", "records": [ "CN-CSR-003", "CN-CSR-004", "TECH-ENERGY-001" ] }, { "no": 3, "name": "CT辐射剂量与DRL", "records": [ "CN-STD-001", "CN-STD-003", "CN-STD-004", "INTL-ICRP-003", "INTL-ICRP-004", "INTL-ICRP-001", "INTL-ICRP-002", "INTL-ICRP-005", "INTL-AAPM-002", "INTL-ESR-001", "INTL-CMS-001", "TECH-DOSE-001", "TECH-DOSE-002", "TECH-DOSE-003" ] }, { "no": 4, "name": "碘对比剂与增强扫描", "records": [ "CN-CSR-015", "CN-CSR-016", "CN-CSR-017", "CN-CSR-018", "INTL-ESUR-001", "TECH-CM-001", "TECH-CM-002", "TECH-CM-003", "TECH-CM-004", "TECH-CM-005" ] }, { "no": 5, "name": "AI/深度学习在CT中的应用", "records": [ "CN-CSR-002", "INTL-AAPM-001", "INTL-CLEAR-001", "INTL-IBSI-001", "INTL-AICCTA-001", "TECH-AI-001", "TECH-AI-002", "TECH-AI-003", "TECH-AI-004", "TECH-AI-005", "TECH-AI-006", "TECH-AI-007", "TECH-AI-008", "TECH-AI-009" ] }, { "no": 6, "name": "CT灌注成像（CTP）", "records": [ "TECH-PERF-001", "TECH-PERF-002" ] }, { "no": 7, "name": "CT血管成像（CTA）扫描与后处理", "records": [ "CN-CSR-005", "CN-CSR-009", "CN-CSR-011", "CN-CSR-021", "TECH-CTA-001", "TECH-CTA-002", "TECH-CTA-003", "TECH-CTA-004" ] }, { "no": 8, "name": "冠状动脉CTA、钙化积分与CT-FFR", "records": [ "CN-CSR-022", "CN-CSR-024", "TECH-CCTA-001", "TECH-CCTA-002", "TECH-CCTA-003", "TECH-CCTA-004", "TECH-CCTA-005", "TECH-CCTA-006", "TECH-CCTA-007", "TECH-CCTA-008", "TECH-CCTA-009" ] }, { "no": 9, "name": "低剂量螺旋CT肺癌筛查与质控", "records": [ "INTL-ACR-002", "INTL-FLE-001", "INTL-NCCN-001", "INTL-USPSTF-001", "INTL-CHEST-001", "INTL-TAIWAN-001", "TECH-LDCT-001", "TECH-LDCT-002", "TECH-LDCT-003", "TECH-LDCT-004", "TECH-LDCT-005" ] }, { "no": 10, "name": "图像质量与扫描参数标准化（AEC/迭代重建）", "records": [ "CN-STD-002", "INTL-AAPM-001" ] }, { "no": 11, "name": "超高端CT/宽体探测器CT", "records": [ "CN-CSR-022", "TECH-WIDE-001" ] }, { "no": 12, "name": "结构化报告与影像数据规范（DICOM/Radiomics）", "records": [ "INTL-CLEAR-001", "INTL-IBSI-001", "TECH-REP-001", "TECH-REP-002", "TECH-CTA-002" ] }, { "no": 13, "name": "4D-CT/动态CT/大范围动态成像", "records": [ "TECH-PERF-001", "TECH-4D-001" ] }, { "no": 14, "name": "儿童CT低剂量技术与质控", "records": [ "CN-STD-001", "CN-CSR-007", "INTL-IG-001", "TECH-DOSE-002" ] }, { "no": 15, "name": "混合手术室/急诊CT", "records": [ "CN-CSR-013", "CN-CSR-014", "CN-CSR-019", "CN-CSR-020", "TECH-ED-001" ] } ], "note_added": "本分册为技术专题通道（15 个技术专题）产出条目的结构化净新增版；已剔除与 guidelines_cn_part1.json 重复的 3 条（CN-CSR-012/013/019）。" }, "records": [ { "id": "TECH-PCCT-001", "cn": "光子计数CT技术专家共识（在研）", "en": "Expert consensus on photon-counting CT technology (in development)", "org": "中国医学装备协会、中华医学会影像技术学会、中国医师协会（协作含北京协和、瑞金、华西、郑大一附院等）", "year": "2026（在研，未发布）", "source": "国际实践指南注册与透明化平台（PREPARE-2026CN1347）", "region": "中国", "cat": "CT新技术/光子计数", "tech": [ "光子计数CT", "协议优化", "质量控制", "能量成像" ], "topics": [ "1. 光子计数CT（PCCT）" ], "summary": "拟系统梳理以光子计数CT技术体系为核心的指导框架，提供从技术选择到临床决策的参考文件，成为设备发挥、协议优化与价值挖掘的技术性基准。截至本清单编制日尚未正式发布。", "points": [ "面向放射科技师/医师/质控人员，聚焦光子计数CT的协议优化与质量控制（与已发布的《光子计数CT临床应用专家共识》形成技术与临床的分工）", "证据分级采用中华医学会临床指南证据分级体系", "预注册号 PREPARE-2026CN1347；状态为在研/计划中，建库须标注版本状态，不得当作已发布内容引用" ], "url": "https://www.guidelines-registry.org/guide/8a5aaae7-3d3d-42be-9f86-a376f3922f43" }, { "id": "TECH-ENERGY-001", "cn": "影像学技术在痛风关节炎中应用的中国专家共识（2025版）", "en": "Chinese expert consensus on the application of imaging techniques in gouty arthritis (2025)", "org": "中华风湿病学杂志相关专家组（发布主体待核实）", "year": "2025", "source": "中华风湿病学杂志，2025，29(1)：1-7（待核实）", "region": "中国", "cat": "CT新技术/能谱", "tech": [ "双能CT", "尿酸盐沉积成像", "痛风", "物质分离" ], "topics": [ "2. 能谱成像/双能CT" ], "summary": "规范影像学技术（含双能CT）在痛风关节炎诊断与疗效评估中的应用，是双能CT尿酸盐沉积成像的国内落地共识之一。", "points": [ "双能CT通过物质分离/双能比色原理识别并定量尿酸盐结晶沉积，是痛风无创诊断的重要能谱应用", "双能CT对痛风诊断的高特异性依赖设备能谱分离能力与后处理算法；与超声、X线等形成互补", "该条目为能谱CT在肌骨/代谢场景的代表性应用共识；具体参数（管电压组合、能谱后处理设置）原文待核实" ], "url": "待核实" }, { "id": "TECH-DOSE-001", "cn": "CT辐射剂量诊断参考水平专家共识", "en": "Expert consensus on diagnostic reference levels for CT radiation dose", "org": "中华医学会放射学分会质量管理与安全管理学组", "year": "2017", "source": "中华放射学杂志，2017，51(11)：817-822", "region": "中国", "cat": "辐射剂量与防护", "tech": [ "诊断参考水平", "CTDIvol", "DLP", "剂量调查" ], "topics": [ "3. CT辐射剂量与DRL" ], "summary": "在 WS/T 637 基础上形成国内 CT 辐射剂量 DRL 的专家共识，规范剂量调查、表征量选择与优化流程。", "points": [ "以 CTDIvol、DLP 作为 DRL 表征量", "工作组采集 5 家医院 448 684 人次（成人 425 763、儿童 22 921）数据，获得成人及儿童各部位 DRL", "胸部参考值：CTDIvol 成人 9 mGy / 儿童 4 mGy；DLP 成人 332 mGy·cm / 儿童 113 mGy·cm", "强调平衡辐射剂量与图像质量，推进区域 DRL 使用" ], "url": "https://med.wanfangdata.com.cn/Paper/Detail?id=zhfsx201711001&dbid=WF_QK" }, { "id": "TECH-DOSE-002", "cn": "儿童CT检查辐射剂量标准中国专家共识", "en": "Expert consensus on radiation dose of children CT examination", "org": "中华医学会儿科学分会影像学组、中华医学会放射学分会儿科学组", "year": "2024", "source": "中华放射学杂志，2024，58(2)：158-164", "region": "中国", "cat": "儿科/辐射剂量", "tech": [ "儿童低剂量", "诊断参考水平", "迭代重建", "CTDIvol", "DLP" ], "topics": [ "3. CT辐射剂量与DRL", "14. 儿童CT低剂量技术与质控" ], "summary": "针对国内缺乏统一儿童CT辐射剂量标准的问题，结合国内外共识与文献，对儿童头颅平扫、鼻窦平扫、颞部平扫、颈部平扫、胸部平扫、腹部平扫、头颅增强、胸部增强、腹部增强的辐射剂量标准达成共识。", "points": [ "按 0-1 个月、1-4 岁、4-10 岁、10-14 岁、14-18 岁五个年龄段分别给出 CTDIvol/DLP 参考剂量", "胸腹部平扫采用第 50 百分位、增强 CT 采用第 75 百分位（与 WS/T 851—2025 的 25/50/75 分位体系一致）", "提出迭代重建可降低 30%–50% 剂量", "针对新生儿颞部、青少年颅脑增强剂量做修正" ], "url": "https://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhfsx202402005" }, { "id": "TECH-DOSE-003", "cn": "心血管CT成像辐射剂量优化中国专家共识", "en": "Chinese expert consensus on radiation dose optimization in cardiovascular CT imaging", "org": "中华医学会放射学分会质量控制与安全管理专业委员会", "year": "待核实", "source": "中华医学会放射学分会（具体期刊卷期待核实）", "region": "中国", "cat": "辐射剂量与防护/心血管", "tech": [ "辐射剂量优化", "前瞻性心电门控", "管电流调制", "低剂量" ], "topics": [ "3. CT辐射剂量与DRL", "8. 冠状动脉CTA" ], "summary": "规范心血管CT成像（含冠状动脉CTA）的辐射剂量优化策略，是心血管CT低剂量技术的重要国内共识。", "points": [ "心血管CT剂量优化的核心技术路径：前瞻性心电门控（序列扫描）替代回顾性门控、管电流/管电压调制、低管电压配合迭代/深度学习重建", "与 WS/T 637 中冠脉CTA DRL（前瞻门控 CTDIvol 40 mGy/DLP 600；回顾门控 60/1030）配套使用", "具体参数阈值原文待核实" ], "url": "待核实" }, { "id": "TECH-CM-001", "cn": "碘对比剂使用指南（第2版）", "en": "Guidelines for the use of iodinated contrast media (2nd edition)", "org": "中华医学会放射学分会对比剂安全使用工作组", "year": "待核实（第2版）", "source": "中华医学会放射学分会", "region": "中国", "cat": "对比剂安全", "tech": [ "碘对比剂", "水化", "对比剂肾病", "非离子型" ], "topics": [ "4. 碘对比剂与增强扫描" ], "summary": "系统规范碘对比剂结构、分类、使用前准备、使用原则、对比剂肾病（CIN）、血管外渗、全身不良反应、禁忌证及血管外使用。", "points": [ "明确对比剂浓度/渗透压/黏滞度选择原则；推荐非离子型对比剂", "水化方案：动脉给药前后 0.9% 生理盐水或碳酸氢钠 ≥100 ml/h 持续 24 h；静脉给药口服补液 100 ml/h", "提出对比剂用量与检查部位/体重匹配原则" ], "url": "https://ima.qq.com/wiki/?shareId=f15a7b29da52441db8bd7f10ce621e0ea6dc6a57872919ab5adb34195df586e2" }, { "id": "TECH-CM-002", "cn": "碘对比剂安全应用中国专家共识", "en": "Chinese expert consensus on the safe application of iodinated contrast media", "org": "中国医师协会放射医师分会", "year": "2025", "source": "中华放射学杂志，2025，59(1)：12-20", "region": "中国", "cat": "对比剂安全", "tech": [ "碘对比剂", "对比剂肾病", "双低方案", "过敏样反应", "注射流率" ], "topics": [ "4. 碘对比剂与增强扫描" ], "summary": "系统规范碘对比剂临床安全应用，涵盖风险因素评估、过敏样反应识别与处理、对比剂肾病预防、特殊人群管理等。", "points": [ "提出不同风险患者的对比剂种类（等渗/次高渗/低浓度）、用量与注射流率选择", "强调必要时降低对比剂剂量（低浓度对比剂 + 低管电压“双低”方案）", "规范不良反应现场处置", "该共识是“对比剂安全”转换为“设备技术卖点”的直接依据：双低方案依赖设备低管电压成像质量与重建算法能力" ], "url": "待核实（原文全文待核实）" }, { "id": "TECH-CM-003", "cn": "碘对比剂临床应用的风险评估管理专家共识", "en": "Expert consensus on risk assessment and management of iodinated contrast media in clinical application", "org": "中华医学会放射学分会（护理学组牵头）", "year": "2025", "source": "临床放射学杂志，2025，44(5)：790-796", "region": "中国", "cat": "对比剂安全", "tech": [ "风险评估", "对比剂肾病", "对比剂选择", "警示标识" ], "topics": [ "4. 碘对比剂与增强扫描" ], "summary": "明确碘对比剂（ICM）高风险、低风险、不确定风险的具体因素及相应管理策略，提出智能预测系统、警示标识、标准化评估流程等措施。", "points": [ "高风险因素包括：既往使用碘对比剂发生中重度不良反应者（风险约为普通人群 5 倍）、不稳定性哮喘、糖尿病肾病、使用肾毒性药物或影响肾小球滤过率药物、肾功能不全、高血压/肺动脉高压/充血性心力衰竭、痛风、其他药物不良反应或过敏史、脱水或血容量不足、血液疾病、70 岁以上老人、新生儿与婴幼儿、妊娠及哺乳期妇女", "强调检查前标准化评估流程与对比剂选择；明确高危及绝对禁忌证", "提出智能预测系统与警示标识等信息化管理手段" ], "url": "https://guide.medlive.cn/guideline/35136" }, { "id": "TECH-CM-004", "cn": "碘美普尔（碘浓度400 mg/ml）肝脏CT应用专家共识", "en": "Expert consensus on the application of iomeprol (400 mg I/ml) in liver CT", "org": "专家共识（中华医学知识库收录）", "year": "待核实", "source": "中华放射学杂志（具体年卷待核实）", "region": "中国", "cat": "对比剂/腹部", "tech": [ "碘流率", "动态增强", "灌注扫描", "管电压", "触发" ], "topics": [ "4. 碘对比剂与增强扫描", "13. 4D-CT/动态CT" ], "summary": "给出基于碘流率、体表面积/体重计算的肝脏CT多期动态增强与灌注扫描方案。", "points": [ "管电压 120 kV（灌注 80 kV）", "监测法：降主动脉 100 HU 触发", "动脉晚期触发后 15–20 s、门静脉期 25–30 s、延迟期 180–300 s", "注射流率 4–5 ml/s、注射时间 20–30 s；碘流率 1.6–2.0 g I/s", "用量按体型：BMI<26 用 520 mg I/kg；BMI≥26 用 18.6 g I/m²" ], "url": "https://training.yiigle.com/uploads/guide_html/碘美普尔（碘浓度400 mg_ml）肝脏CT应用专家共识.html" }, { "id": "TECH-CM-005", "cn": "恶性肿瘤患者CT增强扫描对比剂安全管理专家共识（2022）", "en": "Expert consensus on contrast agent safety management for contrast-enhanced CT in cancer patients (2022)", "org": "中国抗癌协会肿瘤影像专业委员会", "year": "2022", "source": "中华放射学杂志，2022，56(9)：941-949", "region": "中国", "cat": "对比剂安全/肿瘤", "tech": [ "碘对比剂", "CI-AKI", "最小有效碘量", "注射方案" ], "topics": [ "4. 碘对比剂与增强扫描" ], "summary": "在 2017 第 1 版基础上更新，就恶性肿瘤 CT 增强扫描的碘对比剂暴露风险、扫描方案、对比剂注射方案优化及不良反应处理形成共识。", "points": [ "针对肿瘤患者（肿瘤本身/并发症/治疗药物致肾损伤风险）优化增强扫描方案与注射方案", "推荐最小有效碘量", "关注对比剂相关急性肾损伤（CI-AKI）预防" ], "url": "待核实" }, { "id": "TECH-AI-001", "cn": "人工智能应用于肺癌筛诊疗的专家共识（2026版）", "en": "Expert consensus on the application of artificial intelligence in lung cancer screening, diagnosis and treatment (2026)", "org": "中国医师协会胸外科分会、中国抗癌协会非小细胞肺癌专委会等（通信作者：吴一龙、钟文昭）", "year": "2026", "source": "中国胸心血管外科临床杂志，2026", "region": "中国", "cat": "AI/胸部", "tech": [ "AI辅助诊断", "肺结节检出", "图像质控", "泛化性", "外部验证" ], "topics": [ "5. AI/深度学习在CT中的应用" ], "summary": "覆盖肺癌筛查、影像诊断、病理诊断、术前规划、治疗预测、随访全链条；明确 AI 仅为辅助工具，严禁 AI 独立出具诊断报告与制定治疗方案；建立 AI 医疗器械准入、外部验证、质控、数据安全规范。", "points": [ "AI 适用于 LDCT 高危人群筛查，自动检出/分割结节并测量大小、密度、体积、倍增时间", "可辅助质控 LDCT 图像质量、剔除不合格图像", "警示炎症/结核/纤维化假阳性及磨玻璃小结节漏诊", "模型需多中心外部验证，覆盖不同设备与扫描参数（泛化性要求）；须具备 NMPA 注册证", "硬性边界：严禁 AI 独立出具报告与制定治疗方案" ], "url": "https://www.medtranslation.cn/waikeyixue/20260912/269370.html" }, { "id": "TECH-AI-002", "cn": "人工智能在肺结节诊治中的应用专家共识（2022年版）", "en": "Chinese experts consensus on artificial intelligence assisted management for pulmonary nodule (2022 version)", "org": "吴阶平医学基金会模拟医学部胸外科专委会", "year": "2022", "source": "PMC9051301", "region": "中国", "cat": "AI/胸部", "tech": [ "AI辅助诊断", "肺结节", "分割", "随访" ], "topics": [ "5. AI/深度学习在CT中的应用" ], "summary": "LDCT 肺癌筛查推广使肺结节检出率显著提高，AI 协助肺结节良恶性判读及个体化治疗方案的有效性获初步验证；共识为 AI 诊治肺结节提供参考。", "points": [ "明确 AI 在 LDCT 肺结节检出、分割、测量与随访中的角色与局限性", "为后续 2026 版 AI 肺癌共识奠定基础" ], "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9051301/" }, { "id": "TECH-AI-003", "cn": "肝细胞癌诊断的影像组学模型推荐专家共识", "en": "Expert consensus on radiomics model recommendations for the diagnosis of hepatocellular carcinoma", "org": "待核实", "year": "2024", "source": "中华肝脏病杂志，2024，32(7)：631-636", "region": "中国", "cat": "影像组学/AI", "tech": [ "影像组学", "模型推荐", "CT特征", "标准化" ], "topics": [ "5. AI/深度学习在CT中的应用", "12. 结构化报告与影像数据规范" ], "summary": "基于 CT/MRI 的肝细胞癌影像组学模型推荐专家共识，对影像组学在 HCC 诊断中的应用与建模规范提出推荐。", "points": [ "影像组学模型对扫描设备、重建算法、层厚与离散化选择高度敏感——扫描参数标准化程度直接决定模型可迁移性（与 CLEAR/IBSI 的国际结论一致）", "具体建模流程与参数原文待核实" ], "url": "待核实" }, { "id": "TECH-AI-004", "cn": "胸部影像学检查人工智能辅助读片技术在肺结核患者发现中的应用专家共识", "en": "Expert consensus on the application of AI-assisted reading of chest imaging in the detection of pulmonary tuberculosis", "org": "中国防痨协会等（发布主体待核实）", "year": "2025", "source": "中国防痨杂志，2025，47(9)：1093-1104", "region": "中国", "cat": "AI/胸部", "tech": [ "AI辅助诊断", "CAD", "肺结核筛查" ], "topics": [ "5. AI/深度学习在CT中的应用" ], "summary": "规范 AI 辅助胸部影像（含 CT）读片用于肺结核患者发现的应用要求。", "points": [ "明确 AI 在胸部影像结核病灶检出中的辅助定位与质控要求", "具体性能阈值与部署要求待核实原文" ], "url": "待核实" }, { "id": "TECH-AI-005", "cn": "进展期胃癌CT多中心数据库构建及标注专家共识", "en": "Expert consensus on the construction and annotation of a multicenter CT database for advanced gastric cancer", "org": "中华医学会放射学分会及中放医学影像人工智能工作组等", "year": "待核实", "source": "中华医学会放射学分会（期刊卷期待核实）", "region": "中国", "cat": "影像组学/数据规范", "tech": [ "多中心数据库", "数据标注", "质量控制", "结构化标注" ], "topics": [ "5. AI/深度学习在CT中的应用", "12. 结构化报告与影像数据规范" ], "summary": "明确进展期胃癌 CT 多中心数据库的病例纳排标准、采集要求、结构化标注与质量控制，用于支撑影像组学/AI 建模。", "points": [ "要求全周期多期相 CT 采集、结构化标注与质量控制、数据脱敏与标准化存储", "多中心数据库是消除设备差异、增强 AI 泛化性能的基础设施（与 2026 版 AI 肺癌共识的外部验证要求呼应）" ], "url": "待核实" }, { "id": "TECH-AI-006", "cn": "结直肠癌CT影像数据库构建及质量控制专家共识", "en": "Expert consensus on the construction and quality control of a colorectal cancer CT imaging database", "org": "待核实", "year": "待核实", "source": "中华医学会放射学分会相关工作组（待核实）", "region": "中国", "cat": "影像组学/数据规范", "tech": [ "数据库构建", "质量控制", "影像组学" ], "topics": [ "5. AI/深度学习在CT中的应用", "12. 结构化报告与影像数据规范" ], "summary": "规范结直肠癌 CT 影像数据库的构建流程与质量控制要求。", "points": [ "明确病例纳排标准、采集要求、标注规范与质量控制机制", "具体参数原文待核实" ], "url": "待核实" }, { "id": "TECH-AI-007", "cn": "肺癌免疫检查点抑制剂相关肺炎的多模态影像组学与AI动态管理专家共识", "en": "Expert consensus on multimodal radiomics and AI dynamic management of immune checkpoint inhibitor-related pneumonitis in lung cancer", "org": "中国研究型医院学会", "year": "2025", "source": "2025-12-10 发布（期刊出处待核实）", "region": "中国", "cat": "影像组学/AI", "tech": [ "多模态融合", "影像组学", "层厚", "AI泛化" ], "topics": [ "5. AI/深度学习在CT中的应用", "12. 结构化报告与影像数据规范" ], "summary": "针对肺癌免疫检查点抑制剂相关肺炎（CIP）的 CT 影像组学与 AI 动态管理形成共识，规范影像采集流程与多模态建模。", "points": [ "要求规范 CT 影像采集流程，层厚精准控制在 ≤1 mm", "构建多中心数据库以消除设备差异、增强 AI 泛化性能", "整合 3D 影像组学、血清指标与临床数据；多模态融合模型使不典型病例敏感性提高（AUC 达 0.918）" ], "url": "待核实" }, { "id": "TECH-AI-008", "cn": "头颈动脉CT血管成像数据标注与质量控制专家共识（2024）", "en": "Expert consensus on data annotation and quality control of head and neck CT angiography (2024)", "org": "中华医学会放射学分会医学影像人工智能工作组、北京医学会放射学分会人工智能学组、中国食品药品检定研究院（通信作者：刘士远、陈敏、金征宇、卢洁、周俊林）", "year": "2024", "source": "中华放射学杂志，2024，58(2)：150-157，DOI:10.3760/cma.j.cn112149-20230522-00358", "region": "中国", "cat": "AI/头颈", "tech": [ "数据标注", "质量控制", "层厚", "管电压", "管电流", "重建视野", "矩阵" ], "topics": [ "5. AI/深度学习在CT中的应用", "7. CT血管成像（CTA）扫描与后处理", "12. 结构化报告与影像数据规范" ], "summary": "围绕 AI 辅助头颈 CTA 的数据采集、标注与质量控制，建立标准化数据库与质控要求。", "points": [ "建议 64 层及以上 CT 行头颈动脉 CTA", "管电压 80–120 kVp、智能管电流 50–650 mAs", "对比剂 50–60 ml 高浓度非离子型", "扫描层厚 0.500–0.625 mm 无间隔连续扫描；重建层厚 0.500–0.625 mm、重建视野 17–25 cm、像素 0.330–0.390 mm", "金属植入术后采用二次迭代重建减少线束硬化伪影", "图像矩阵 ≥512×512，增强图像层厚 <2 mm" ], "url": "https://www.brainmed.com/info/detail?id=47109" }, { "id": "TECH-AI-009", "cn": "CT深度学习图像重建算法临床应用规范（团体标准）", "en": "Clinical application specification for deep learning image reconstruction algorithms in CT (group standard)", "org": "团体标准（发布机构待核实）", "year": "2025", "source": "团体标准，2025", "region": "中国", "cat": "图像重建算法", "tech": [ "深度学习重建", "图像质量评价", "CNR", "伪影抑制", "临床验证" ], "topics": [ "5. AI/深度学习在CT中的应用", "10. 图像质量与扫描参数标准化" ], "summary": "对 CT 深度学习图像重建算法临床应用的图像质量评价与验证要求作出规范，与《CT深度学习图像重建算法临床应用中国专家共识》配套。", "points": [ "客观指标：计算创伤出血灶与周围组织的 CNR；测量快速扫描下主动脉夹层内膜瓣的显示分辨率；量化颅脑 CTA 的血管截断伪影指数", "主观评估：脑疝、气胸、肠穿孔等急症的诊断信心；金属植入物条纹伪影抑制效果", "临床验证：卒中患者 6 小时时间窗内的诊断时效性；多发伤患者的诊断准确性" ], "url": "待核实" }, { "id": "TECH-PERF-001", "cn": "动态CT心肌灌注成像技术操作与图像分析中国专家共识", "en": "Chinese expert consensus on the technical operation and image analysis of dynamic CT myocardial perfusion imaging", "org": "中华医学会放射学分会等（牵头学组待核实）", "year": "2022", "source": "中华放射学杂志，2022，56(12)：1289-1299", "region": "中国", "cat": "CT灌注/心血管", "tech": [ "动态CT灌注", "心肌灌注", "4D成像", "图像分析" ], "topics": [ "6. CT灌注成像（CTP）", "13. 4D-CT/动态CT" ], "summary": "规范动态 CT 心肌灌注的扫描操作与图像分析，是国内 CT 灌注（动态负荷）在心脏领域的代表性共识。", "points": [ "动态CT心肌灌注属大范围动态（4D）成像，对设备时间分辨率、探测器覆盖宽度与低剂量技术提出综合要求", "需与冠状动脉CTA联合实现冠心病“一站式”解剖+功能评估（与《能量CT临床应用中国专家共识》的能量CTA联合心肌灌注内容呼应）", "具体扫描参数（管电压、对比剂流率、采集时相）原文待核实" ], "url": "待核实" }, { "id": "TECH-PERF-002", "cn": "脑血管病影像规范化应用中国指南（含 CTP 规范）", "en": "Chinese guideline for standardized application of imaging in cerebrovascular disease (including CTP)", "org": "中华医学会放射学分会等", "year": "待核实", "source": "中华放射学杂志（卷期待核实）", "region": "中国", "cat": "CT灌注/神经", "tech": [ "CT灌注", "头颅CTA", "头颅CTV", "团注流率" ], "topics": [ "6. CT灌注成像（CTP）", "7. CT血管成像（CTA）" ], "summary": "规范脑血管病影像检查流程，涵盖头颅 CTA、颈部 CTA、头颅 CTV、CTP 的检查前准备、扫描参数与后处理。", "points": [ "颈部 CTA 自主动脉弓至颅底 Willis 环（可至颅顶），层厚 0.5–1.5 mm，重建间隔取层厚一半", "头颅 CTV 团注非离子型对比剂流率 3.5–4.0 ml/s、总量 80–100 ml（1.5 ml/kg）", "CTP 静脉团注流率 5–6 ml/s，可选全脑容积或部分灌注，CTP 与注射同步启动", "CTP 用于核心梗死与缺血半暗带评估，是急性缺血性卒中一站式（NCCT+CTA+CTP）方案的技术组成" ], "url": "https://www.sohu.com/a/358863319_779471" }, { "id": "TECH-CTA-001", "cn": "急性肺血栓栓塞症CTPA扫描与诊断报告专家共识（2025版）", "en": "Expert consensus on CTPA scanning and diagnostic reporting for acute pulmonary thromboembolism (2025)", "org": "国家心血管病专业质控中心心血管影像质控专家工作组", "year": "2025", "source": "国际实践指南注册 PREPARE-2025CN1879；正式发表版本见《急性肺血栓栓塞症计算机断层扫描肺动脉血管成像检查与诊断报告书写规范专家共识（2026版）》", "region": "中国", "cat": "心血管/胸部", "tech": [ "CTPA", "团注追踪", "薄层重建", "迭代重建", "结构化报告" ], "topics": [ "7. CT血管成像（CTA）扫描与后处理", "12. 结构化报告与影像数据规范" ], "summary": "规范 APTE 的 CTPA 优化扫描方案、对比剂标准、图像后处理、诊断术语与结构化报告。", "points": [ "扫描范围肺尖至膈下，完整覆盖肺动脉主干-叶-段-亚段", "推荐团注追踪（bolus-tracking）肺动脉主干阈值触发", "薄层重建层厚 ≤1 mm，常规输出轴位/冠状/矢状 MPR", "采用迭代重建、个体化 mA 控制有效剂量", "图像质量三级分类（可诊断/受限可诊断/非诊断）；非诊断图像不得出“未见肺栓塞”阴性结论（明确合规红线）" ], "url": "http://www.guidelines-registry.org/guide/b2241796-87af-4fb2-8351-192475688b39" }, { "id": "TECH-CTA-002", "cn": "急性主动脉综合征CTA诊断报告书写规范中国专家共识", "en": "Chinese expert consensus on CTA diagnostic reporting standards for acute aortic syndrome", "org": "国家外周血管介入技术医疗质量控制中心专家委员会主动脉疾病专家工作组、国家心血管系统疾病医疗质量控制中心心血管影像工作组", "year": "待核实", "source": "指南网收录（guide.medlive.cn 编号 38029）", "region": "中国", "cat": "心血管/结构化报告", "tech": [ "主动脉CTA", "结构化报告", "测量标准", "报告分级" ], "topics": [ "7. CT血管成像（CTA）扫描与后处理", "12. 结构化报告与影像数据规范" ], "summary": "针对主动脉 CTA 诊断报告内容完整性与测量规范性差异，规范报告书写；系统提出主动脉夹层、壁内血肿、穿通性溃疡报告应含指标项，明确定义与测量标准，分核心报告项/推荐报告项/可选附加项三级。", "points": [ "主动脉 CTA 为急性主动脉综合征（AAS）首选影像学检查方法", "报告项分三级：核心报告项/推荐报告项/可选附加项", "提供标准化、结构化报告框架（可视为国内主动脉方向“结构化报告”代表文件）" ], "url": "https://guide.medlive.cn/index.php/guideline/38029" }, { "id": "TECH-CTA-003", "cn": "主动脉夹层CT血管成像标注专家共识", "en": "Expert consensus on annotation of CT angiography for aortic dissection", "org": "待核实", "year": "2024", "source": "中华放射学杂志，2024，58(3)：250-257", "region": "中国", "cat": "心血管/数据标注", "tech": [ "主动脉夹层", "图像标注", "数据规范" ], "topics": [ "7. CT血管成像（CTA）扫描与后处理", "12. 结构化报告与影像数据规范" ], "summary": "规范主动脉夹层 CTA 图像标注，用于支撑 AI/影像组学建模与质控。", "points": [ "对主动脉夹层 CTA 的标注内容、标注流程与质控提出要求", "具体标注要素原文待核实" ], "url": "待核实" }, { "id": "TECH-CTA-004", "cn": "CT血管成像技术扫描与图像质量控制（CTA 通用技术要求集结）", "en": "CTA scanning and image quality control — consolidated technical requirements", "org": "综合条目：国家卫生行业标准 + 学会共识", "year": "2018–2026", "source": "由 WS/T 391—2024《CT检查操作规程》、WS/T 519—2019 及各部委/学会 CTA 共识汇总（本条为专题整合条目，非单一文件）", "region": "中国", "cat": "CTA通用/技术规范", "tech": [ "CTA扫描", "图像质量控制", "MPR", "MIP", "VR", "CPR" ], "topics": [ "7. CT血管成像（CTA）扫描与后处理" ], "summary": "整合散见于各 CTA 共识与行业标准中的通用扫描与后处理技术要求，作为 CTA 专题的横向技术索引。", "points": [ "后处理技术矩阵：MPR（多平面重组）、MIP（最大密度投影）、MinIP（最小密度投影）、CPR（曲面重组）、SSD（表面遮盖显示）、VR（容积再现）为各共识的标准配置", "头颈 CTA 图像质量标准：颈部动脉 CT 值 300–350 HU、静脉 ≤150 HU；MPR 层厚 5 mm、窗宽 350 HU/窗位 50 HU", "设备性能允许时优先选能量减影 CTA 扫描模式（去钙化/骨骼）", "本条为整合条目，具体参数请回溯各原始文件" ], "url": "待核实" }, { "id": "TECH-CCTA-001", "cn": "心脏冠状动脉CT血管成像技术规范化应用中国指南", "en": "Chinese guideline for standardized technical application of coronary CT angiography", "org": "中华医学会放射学分会等", "year": "2017", "source": "中华放射学杂志，2017，51(10)", "region": "中国", "cat": "心血管/技术规范", "tech": [ "冠状动脉CTA", "心率控制", "心电门控", "对比剂注射" ], "topics": [ "8. 冠状动脉CTA" ], "summary": "规范心脏冠状动脉 CT 血管成像技术应用。", "points": [ "CCTA 扫描准备、心率控制、心电门控方式、对比剂注射与后处理规范（原文细节待核实）", "是后续 CAD-RADS 国内落地与 CCTA 技术共识的基础文件之一" ], "url": "https://www.pumch.cn/detail/42906.html" }, { "id": "TECH-CCTA-002", "cn": "冠状动脉CT血管成像扫描与报告书写专家共识", "en": "Expert consensus on coronary CTA scanning and report writing", "org": "待核实（北京协和医院相关）", "year": "2019", "source": "DOI:10.3969/j.issn.1674-9081.2019.01.005", "region": "中国", "cat": "心血管/结构化报告", "tech": [ "冠状动脉CTA", "结构化报告", "扫描参数" ], "topics": [ "8. 冠状动脉CTA", "12. 结构化报告与影像数据规范" ], "summary": "规范 CCTA 扫描方案与结构化报告书写。", "points": [ "CCTA 扫描参数与报告要素规范化（原文细节待核实）", "国内 CCTA 结构化报告的早期规范文件之一" ], "url": "https://www.pumch.cn/detail/42906.html" }, { "id": "TECH-CCTA-003", "cn": "冠状动脉CT血管成像最新临床应用推荐及诊断规范", "en": "Updated clinical application recommendations and diagnostic standards for coronary CTA", "org": "待核实", "year": "2022", "source": "中华放射学杂志，2022，56(10)：1160-1164，DOI:10.3760/cma.j.cn112149-20220630-00555", "region": "中国", "cat": "心血管/诊断规范", "tech": [ "冠状动脉CTA", "诊断规范", "临床应用" ], "topics": [ "8. 冠状动脉CTA" ], "summary": "CCTA 最新临床应用推荐及诊断规范。", "points": [ "CCTA 临床应用与诊断规范化（原文细节待核实）" ], "url": "https://www.pumch.cn/detail/42906.html" }, { "id": "TECH-CCTA-004", "cn": "冠状动脉CT血流储备分数应用中国专家建议", "en": "Chinese expert recommendations on the application of coronary CT-derived fractional flow reserve", "org": "中华医学会放射学分会质量控制与安全管理专业委员会等", "year": "2020", "source": "中国循环杂志（转载）", "region": "中国", "cat": "心血管/CT-FFR", "tech": [ "CT-FFR", "探测器排数", "缺血特异性狭窄", "诊断界值" ], "topics": [ "8. 冠状动脉CTA" ], "summary": "规范 CT-FFR 技术原理、工作流程、注意事项与临床应用。", "points": [ "推荐 CCTA 至少在 64 排探测器以上 CT 设备完成", "CT-FFR 主要适应证为 CCTA 示狭窄 30%–70% 病变", "推荐病变水平（狭窄远端 2–3 cm）CT-FFR 值判别缺血特异性狭窄，同时报告血管水平值", "病变远端 CT-FFR>0.80 认为不引起缺血" ], "url": "https://www.toutiao.com/article/6891386362298106376" }, { "id": "TECH-CCTA-005", "cn": "CT血流储备分数操作规范及临床应用中国专家共识", "en": "Chinese expert consensus on the operational specification and clinical application of CT-FFR", "org": "中华医学会放射学分会等", "year": "待核实", "source": "DOI:10.3760/cma.j.cn112149-20221215-01005", "region": "中国", "cat": "心血管/CT-FFR", "tech": [ "CT-FFR", "灰区", "界值", "ΔCT-FFR" ], "topics": [ "8. 冠状动脉CTA" ], "summary": "规范 CT-FFR 操作和临床应用。", "points": [ "CT-FFR 推荐适用范围 30%–90% 狭窄病变", "灰区设于 0.76–0.80；以 0.80（阴性）为界值", "管腔细小/弥漫性病变建议用 ΔCT-FFR>0.12 提示功能学意义", "基于 CCTA 图像无需额外辐射/检查" ], "url": "https://medphy.yiigle.com/uploads/guide_html/5432.html" }, { "id": "TECH-CCTA-006", "cn": "冠状动脉CT血管成像在慢性冠脉综合征的风险分层和诊疗中应用的专家共识（2025年）", "en": "Expert consensus on the application of coronary CTA in risk stratification and management of chronic coronary syndrome (2025)", "org": "中华医学会心血管病学分会、中国老年医学学会、中华心血管病杂志编辑委员会（通信作者：陈绍良、曹丰、韩雅玲、季福绥）", "year": "2025", "source": "中华心血管病杂志，2025，53(1)", "region": "中国", "cat": "心血管", "tech": [ "冠状动脉CTA", "CT-FFR", "斑块性质", "风险分层" ], "topics": [ "8. 冠状动脉CTA" ], "summary": "结合国内外 CCTA 指南/共识及最新临床试验，对 CCTA 在慢性冠脉综合征门诊筛查、风险预警、辅助药物及介入治疗策略制定中的应用进行总结。", "points": [ "CCTA 通过测定血管结构狭窄、斑块性质及血流储备功能（CT-FFR）参数发挥作用", "规范 CCTA 扫描与风险分层应用" ], "url": "待核实" }, { "id": "TECH-CCTA-007", "cn": "经导管主动脉瓣置换术CT检查技术中国专家共识", "en": "Chinese expert consensus on CT examination techniques for transcatheter aortic valve replacement", "org": "中国医师协会放射医师分会心血管学组、国家心血管病专业质控中心心血管影像质控专家工作组、中国研究型医院学会心血管影像专业委员会", "year": "待核实", "source": "中华放射学杂志（配套两篇：《CT检查技术》与《CT规范化评估》）", "region": "中国", "cat": "心血管/结构性心脏病", "tech": [ "心电门控", "全时相CTA", "瓣钙化定量", "大范围螺旋", "对比剂方案" ], "topics": [ "8. 冠状动脉CTA", "11. 超高端CT/宽体探测器CT" ], "summary": "规范 TAVR 相关 CT 检查方案（患者准备、扫描、对比剂使用等）与术前评估内容。", "points": [ "采用心电门控非增强 CT 量化主动脉瓣钙化；心电门控全时相 CT 血管造影评估主动脉根部解剖；大范围非心电门控螺旋 CTA 评估主髂动脉通路——一次检查内需三种不同扫描模式，对设备门控能力、覆盖范围与模式切换能力提出综合要求", "明确 TAVR 术前 CTA 的患者准备与禁忌证（碘对比剂/电离辐射相对禁忌）", "主动脉根部解剖评估以心电门控全时相 CTA 为金标准；3 个关键评估目标：钙化负荷与分布、主动脉根部立体解剖、主髂动脉通路", "AI 自动分割与三维重建、数值仿真“虚拟试错”预测锚定/瓣周漏/冠脉阻塞风险" ], "url": "待核实" }, { "id": "TECH-CCTA-008", "cn": "心脏CT在经导管左心耳封堵术规划中的应用专家共识（2024）", "en": "Expert consensus on the application of cardiac CT in planning transcatheter left atrial appendage occlusion (2024)", "org": "待核实", "year": "2024", "source": "期刊出处待核实", "region": "中国", "cat": "心血管/结构性心脏病", "tech": [ "心脏CT", "左心耳", "术前规划", "测量" ], "topics": [ "8. 冠状动脉CTA" ], "summary": "规范左心耳封堵术前心脏 CT 的规划与测量。", "points": [ "心脏CT为左心耳封堵术前规划提供左心耳形态学与尺寸测量依据", "具体测量参数原文待核实" ], "url": "待核实" }, { "id": "TECH-CCTA-009", "cn": "冠状动脉疾病报告与数据系统 2.0（CAD-RADS 2.0）", "en": "Coronary Artery Disease Reporting and Data System 2.0 (CAD-RADS 2.0)", "org": "SCCT / ACR / ACC / NASCI 联合发布（2024）", "year": "2024", "source": "Journal of Cardiovascular Computed Tomography / Radiology（2024）", "region": "国际", "cat": "心血管/结构化报告", "tech": [ "CAD-RADS", "结构化报告", "钙化积分", "HRP", "斑块负荷" ], "topics": [ "8. 冠状动脉CTA", "12. 结构化报告与影像数据规范" ], "summary": "对 CCTA 报告进行标准化分级（0–5 级）并加入修饰符，是国际 CCTA 结构化报告的通行标准，与国内《冠心病CT检查和诊断中国专家共识（2024）》配套。", "points": [ "分级体系：CAD-RADS 0（无斑块/狭窄）至 5（至少一支血管完全闭塞）；以最狭窄病变定义整体等级", "修饰符体系：P1–P4（斑块负荷）、HRP（高危斑块特征）、I（缺血）、E（例外）、S（支架）、G（移植血管）、N（非诊断性）", "与冠状动脉钙化积分（CACS，Agatston）配合使用；CACS 分级 0 / 1–99 / 100–299 / 300–999 / ≥1000", "CT-FFR 结果可作为功能学修饰纳入报告" ], "url": "待核实" }, { "id": "TECH-LDCT-001", "cn": "中国肺癌低剂量CT筛查指南（2025年版）", "en": "China national lung cancer screening guideline with low-dose computed tomography (2025 version)", "org": "中国肺癌早诊早治专家组、中国西部肺癌研究协作中心（国家卫健委指定）", "year": "2025", "source": "中国肺癌杂志，2025，28(12)：887-895（2025-12-31 发布）", "region": "中国", "cat": "肺癌筛查", "tech": [ "LDCT", "层厚", "有效剂量", "AI辅助", "结节随访" ], "topics": [ "9. 低剂量螺旋CT肺癌筛查与质控" ], "summary": "在 2023 版基础上修订，明确高危人群职业暴露年限、新增停止筛查条件；更新结节大小测量（平均直径）；基线阳性阈值提高至 6 mm、复查时间调整为 3–6 个月；强调知情同意与共同决策。", "points": [ "LDCT 为唯一推荐筛查手段（摒弃胸片）", "建议 16 排及以上多排螺旋 CT", "层厚 ≤1.25 mm，双窗观察", "有效剂量 <1 mSv", "推荐 AI 辅助诊断；结节以平均直径衡量与随访" ], "url": "https://pdfs.semanticscholar.org/92f9/ddb9f65b0d12b89b738fffae360643fffc29.pdf" }, { "id": "TECH-LDCT-002", "cn": "肺癌筛查低剂量CT检查技术规范——专家共识", "en": "Technical specification for low-dose CT examination in lung cancer screening — expert consensus", "org": "中华医学会影像技术分会（康承欣、付彬洁、吕发金、李真林、余建明等）", "year": "待核实", "source": "重庆医科大学学报，DOI:10.13406/j.cnki.cyxb.003594", "region": "中国", "cat": "肺癌筛查/技术规范", "tech": [ "LDCT", "管电压", "管电流", "重建卷积核", "扫描范围", "后处理" ], "topics": [ "9. 低剂量螺旋CT肺癌筛查与质控" ], "summary": "提供规范化肺癌筛查胸部 LDCT 检查方案，覆盖检查适用对象、扫描技术参数、辐射剂量范围、图像质量控制标准。", "points": [ "LDCT 有效辐射剂量应 ≤1 mSv", "按 BMI 分组推荐管电压：BMI<18.5 用 ≤100 kV；18.5–24.9 用 100–120 kV；≥25 用 120 kV", "管电流量按 BMI 分档：20 / 30 / 30 mAs", "重建卷积核建议标准或中等大小", "扫描范围按椎体棘突标志制定：BMI≥21 取 T1 棘突上缘–T12 棘突下缘；BMI<21 取 T1–L1", "深吸气末屏气扫描；后处理推荐 MPR、10 mm 层厚 MIP、3 mm 层厚 MinIP、多层面 VR" ], "url": "https://cjournal.hep.com.cn/0253-3626/CN/10.13406/j.cnki.cyxb.003594" }, { "id": "TECH-LDCT-003", "cn": "低剂量螺旋CT肺癌筛查专家共识", "en": "Expert consensus on low-dose spiral CT lung cancer screening", "org": "中华医学会放射学分会心胸学组", "year": "待核实", "source": "中华放射学杂志（卷期待核实）", "region": "中国", "cat": "肺癌筛查", "tech": [ "LDCT", "高危人群", "筛查频次" ], "topics": [ "9. 低剂量螺旋CT肺癌筛查与质控" ], "summary": "定义肺癌高危人群并推荐每年一次低剂量螺旋 CT 检查。", "points": [ "高危人群为 45–70 岁、有吸烟史、有毒有害物质接触史、恶性肿瘤家族史", "建议每年 LDCT 筛查" ], "url": "待核实" }, { "id": "TECH-LDCT-004", "cn": "中华医学会肺癌临床诊疗指南（2024版）——LDCT 技术参数部分", "en": "Chinese Medical Association clinical practice guideline for lung cancer (2024) — LDCT technical parameters", "org": "中华医学会", "year": "2024", "source": "中华医学会肺癌临床诊疗指南（2024版）", "region": "中国", "cat": "肺癌筛查/诊疗指南", "tech": [ "LDCT", "管电压", "管电流", "层厚", "重建间隔", "窗宽窗位", "矩阵" ], "topics": [ "9. 低剂量螺旋CT肺癌筛查与质控" ], "summary": "肺癌筛查、诊断、治疗全流程指南，其 LDCT 技术参数要求是国内肺癌筛查的重要技术锚点。", "points": [ "建议 16 排及以上多排螺旋 CT 行 LDCT 肺癌筛查", "受检者仰卧、吸气末 1 次屏气完成；扫描范围肺尖至肋膈角", "扫描矩阵不低于 512×512", "管电压 100–120 kVp、管电流 ≤40 mAs", "原始数据用肺算法或标准算法薄层重建；重建层厚 0.625–1.25 mm、层间 20%–30% 重叠", "结节检测采用三维重建、最大密度投影重建", "阅片用肺窗（窗宽 1500–1600 HU/窗位 -50～-600 HU）与纵隔窗（窗宽 350–380 HU/窗位 25–40 HU）" ], "url": "https://www.huxijie.com/documents/头条/9131" }, { "id": "TECH-LDCT-005", "cn": "ACR–STR 肺癌筛查胸部CT检查与报告实践参数", "en": "ACR–STR Practice Parameter for the Performance and Reporting of Lung Cancer Screening Thoracic Computed Tomography", "org": "美国放射学会（ACR）与美国胸科放射学会（STR）", "year": "持续更新", "source": "ACR Practice Parameters（与 Lung-RADS、NCCN、USPSTF、CHEST 推荐配套使用）", "region": "国际-美国", "cat": "肺癌筛查/技术规范", "tech": [ "LDCT", "探测器准直", "旋转时间", "管电压", "AEC", "重建算法", "SSDE" ], "topics": [ "9. 低剂量螺旋CT肺癌筛查与质控" ], "summary": "ACR 实践参数中规范肺癌筛查胸部 CT 技术操作与报告要素的文件，是国际肺癌筛查的技术锚点，与适宜性标准（回答“该不该做”）分工为“该怎么做、怎么报告”。", "points": [ "探测器准直：最薄探测器通道配置（如 64×0.625 mm、128×0.6 mm）或重建层厚 ≤1 mm 的等效配置", "单次屏气完成；球管旋转时间 ≤0.5 s", "管电压 100–120 kVp（肥胖患者可适当提高）", "管电流采用自动曝光控制（AEC）或按患者体型设定的固定管电流；需具备管电流调制（TCM）能力", "重建算法须为滤波反投影、迭代重建或深度学习重建；重建层厚 ≤2.5 mm，推荐 ≤1.25 mm（重建间隔通常 ≤1 mm）；重建算法为高空间频率（肺）算法", "辐射剂量：CTDIvol ≤3 mGy（标准体型）、SSDE ≤3 mGy、有效剂量 ≤1 mSv；须记录并报告 DLP 与 CTDIvol", "扫描时间（屏气）≤10 s；报告须采用 Lung-RADS 结构化格式" ], "url": "https://www.acr.org/Clinical-Resources/Practice-Parameters-and-Technical-Standards" }, { "id": "TECH-WIDE-001", "cn": "急性胸痛三联征多层螺旋CT检查技术专家共识", "en": "Expert consensus on triple-rule-out CT angiography examinations in patients with acute chest pain", "org": "中华医学会影像技术分会（通信作者：余建明、李真林）", "year": "2021", "source": "中华放射学杂志，2021，55(1)：12-18，DOI:10.3760/cma.j.cn112149-20200102-00004", "region": "中国", "cat": "心血管/急诊/宽体探测器", "tech": [ "宽体探测器", "高时间分辨率", "低剂量", "三联CT", "图像质量控制" ], "topics": [ "11. 超高端CT/宽体探测器CT", "15. 混合手术室/急诊CT" ], "summary": "规范急诊胸痛三联征（ACS、PE、AD）多层螺旋 CT 的检查前准备、扫描方案、图像后处理、图像质量控制与辐射剂量控制。", "points": [ "一次扫描同时评估冠状动脉、肺动脉、胸主动脉", "技术前提为宽体探测器 + 高时间分辨率 + 低辐射剂量技术三者的组合", "规范数据采集标准化、图像后处理及对比剂注射规范", "建立急诊-放射科绿色通道", "是宽体探测器/超高端CT临床价值的代表性共识依据" ], "url": "https://rs.yiigle.com/cmaid/1307114" }, { "id": "TECH-REP-001", "cn": "中国结直肠癌诊疗规范（2020/2023版）——CT 结构化报告模板", "en": "Chinese guideline for the diagnosis and treatment of colorectal cancer (2020/2023) — structured CT reporting template", "org": "国家卫生健康委员会", "year": "2020（延用至2023版）", "source": "国家卫生健康委员会", "region": "中国", "cat": "结构化报告", "tech": [ "结构化报告", "EMVI", "CRM", "肿瘤分期" ], "topics": [ "12. 结构化报告与影像数据规范" ], "summary": "结直肠癌诊疗规范，含 CT 影像结构化报告模板。", "points": [ "强烈推荐结直肠癌结构化报告模板，含肿瘤位置、浸润深度及与周围结构关系、区域淋巴结、EMVI（直肠周围血管侵犯）、CRM（环周切缘）、远处转移等要素", "推荐 CT 作为结直肠癌常用影像学检查方法；推荐胸部 CT 平扫" ], "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10334494/" }, { "id": "TECH-REP-002", "cn": "中国大陆 CT 结构化报告规范现状（专题结论条目）", "en": "Status of CT structured reporting standards in mainland China — topical conclusion entry", "org": "综合结论（由 tech-topics 与 cn-guidelines 交叉核实）", "year": "2026", "source": "跨文件综合结论", "region": "中国", "cat": "结构化报告/数据规范", "tech": [ "结构化报告", "DICOM", "RDSR", "规范缺位" ], "topics": [ "12. 结构化报告与影像数据规范" ], "summary": "检索结论：中国大陆目前未见通用的《CT结构化报告通用规范》，现有均为按病种/部位的结构化报告。建议建库时按“通用规范缺位、病种规范齐备”处理。", "points": [ "已具备病种级结构化报告：冠心病 CCTA（含 CAC 视觉评估、Agatston 分级、18 段冠脉分段、CT-FFR 报告）、CT 小肠造影、胃癌（华西规范）、子宫颈癌（Node-RADS）、急性主动脉综合征、CTPA、结直肠癌", "通用规范（如 DICOM 结构化报告 RDSR、IHE REM 剂量档案、MITA XR-29 等设备侧数据规范）主要来自国际标准组织，中国尚无对应国家级通用规范——属知识库明确记录的“空缺项”", "该结论对产品侧意义：结构化报告/剂量档案的数据规范能力目前缺少国内强制标准约束，是设备差异化的空间" ], "url": "待核实（综合结论，无单一来源）" }, { "id": "TECH-4D-001", "cn": "腹部（肝脏/胰腺）CT 灌注与动态成像技术规范（专题整合条目）", "en": "Abdominal (liver/pancreas) CT perfusion and dynamic imaging — consolidated technical entry", "org": "综合条目：由《CT检查技术专家共识》及《碘美普尔（碘浓度400 mg/ml）肝脏CT应用专家共识》汇总", "year": "2016–2025", "source": "跨文件整合（本条为专题整合条目，非单一文件）", "region": "中国", "cat": "CT灌注/动态成像", "tech": [ "CT灌注", "电影扫描", "高流率", "管电压", "大范围动态" ], "topics": [ "13. 4D-CT/动态CT" ], "summary": "整合腹部 CT 灌注与动态（4D）成像的技术要求，作为动态 CT 专题的技术索引。", "points": [ "肝脏/胰腺灌注：注射流率 4.0–8.0 mL/s、对比剂 50 mL、灌注时间 30–40 s、电影扫描采集", "灌注扫描推荐低管电压（80 kV）以提升碘对比度", "4D/动态成像对设备时间分辨率、探测器覆盖宽度与低剂量技术提出综合要求" ], "url": "待核实" }, { "id": "TECH-ED-001", "cn": "腹部钝性损伤CT检查规范和临床应用中国专家共识", "en": "Chinese expert consensus on the specifications and clinical application of CT examination for blunt abdominal trauma", "org": "中国医师协会放射医师分会、中华医学会创伤学分会", "year": "2023", "source": "中华放射学杂志，2023，57(7)：723-732", "region": "中国", "cat": "急诊/腹部", "tech": [ "创伤CT", "增强期相", "图像后处理", "征象判读" ], "topics": [ "15. 混合手术室/急诊CT", "6. CT灌注成像（CTP）" ], "summary": "对腹部钝性损伤 CT 检查前准备、CT 扫描方案、图像后处理技术应用及腹部实质和空腔脏器损伤 CT 征象解读达成共识。", "points": [ "规范腹部创伤 CT 扫描方案（平扫/增强期相、图像后处理技术应用）", "统一腹部各脏器损伤征象判读；旨在规范 CT 检查技术、正确识别征象", "具体期相延迟与管电压参数原文待核实" ], "url": "https://guide.medlive.cn/guide_v2/1/29238" } ] }